IPD NMA ANCOVA results: EQ-5D preference score and SMD endpointsa | Model 1, ANCOVA, change in outcome score, adjusted for baseline median MCMC posterior sample (95Â % CrI) | |||
---|---|---|---|---|
Change EQ-5D | Change standardised pain | |||
Relative treatment effects | Osteoarthritis of the knee | SHAM vs UC | 0.057 (0.013, 0.095) | 0.271 (-0.007, 0.537) |
ACU vs UC | 0.079 (0.042, 0.114) | 0.703 (0.399, 0.984) | ||
ACU vs SHAM | 0.022 (-0.014, 0.060) | 0.438 (0.121, 0.715) | ||
Headache | SHAM vs UC | 0.052 (0.010, 0.095) | 0.332 (0.022, 0.669) | |
ACU vs UC | 0.056 (0.021, 0.092) | 0.588 (0.311, 0.869) | ||
ACU vs SHAM | 0.004 (-0.035, 0.042) | 0.256 (-0.073, 0.560) | ||
Musculoskeletal | SHAM vs UC | 0.059 (0.017, 0.101) | 0.063 (-0.241, 0.378) | |
ACU vs UC | 0.082 (0.047, 0.116) | 0.588 (0.334, 0.863) | ||
ACU vs SHAM | 0.023 (-0.008, 0.053) | 0.527 (0.323, 0.735) | ||
 | Between-study variance | 0.001 (0, 0.003) | 0.090 (0.049, 0.170) | |
Total residual deviance b | 15,850 (15,480; 16, 230) | 17,060 (16,660; 17,450) | ||
Deviance information criterion c | -6,420.4 | 37,394.2 |